Sabinsa's DigeZyme Shows Benefit For Delayed Onset Muscle Soreness

644ad912-43c1-4bf7-94f6-5f41f6bdf6b0articleimage.jpg

11 Jan 2017 --- New Research has shown that Sabinsa's multi-enzyme complex DigeZyme, a proprietary blend of non-animal sourced enzymes potential for more rapid recovery from Delayed Onset Muscle Soreness (DOMS). The study was published in Sports Nutrition and Therapy.

Delayed onset muscle soreness (DOMS) is one of the outcomes of inflammation due to microscopic wear and tear in the muscles caused by strenuous exercise.

While some muscle soreness is typical of any exercise regimen and usually peaks around 36-48 hours after the exercise event, in athletes or even regular gym-goers unaccustomed or high-intensity exercise may lead to sustained inflammatory response, causing prolongation of skeletal muscle recovery.

DOMS may lead to passive stiffness, swelling and pain in muscles, which may affect performance as well as recovery.

In this prospective, double-blind, randomized, placebo-controlled trial on 20 healthy male subjects, the analgesic effect of DigeZyme in management of DOMS were compared to placebo.

While DigeZyme’s role in supporting improved digestive health is well recognized, this is the first attempt to evaluate its role in DOMS resulting from muscle overload or strenuous exercise.

Supplementation with 50 mg of DigeZyme three times a day demonstrated significant improvement in both subjective pain and muscle tenderness after eccentric exercise.

This study establishes the role of DigeZyme in sports nutrition, especially as a post-exercise recovery supplement. DigeZyme is available as a powdered blend which can be mixed with other sports nutrition ingredients as well commercialized as a standalone product.

“This new study, gives a new twist to a classic product of ours, DigeZyme,” said Sabinsa Marketing Director Shaheen Majeed.

“Well known for use in digestive health, we have now studied DigeZyme for this specific sports indication. Enzymes have been part of the sports supplements category, and DigeZyme has enjoyed its place in many sports products, mainly to have enzymes breakdown proteins and carbohydrates.”

“Sabinsa has now given an additional clinical indication that no other enzyme blend has done before - DOMS. Our blend for this indication is now patent pending.”

Related Articles

Business News

BASF: “considerable” Q2 earnings growth, but Nutrition & Health sales stall

27 Jul 2017 --- BASF Group has announced that its second quarter sales rose by 12 percent to €16.3 billion (US$19.11 billion) compared with the same period in 2016. The group states that this was largely attributable to higher prices and volumes. Amid higher raw material costs, the company raised sales prices by 7 percent; this was mainly driven by higher prices in the Chemicals segment. Sales volumes increased by 3 percent. Currency effects had a positive impact on sales and, like portfolio effects, accounted for a 1 percent increase.

Regulatory News

Cargill’s erythritol dental health claim rejected by EFSA

27 Jul 2017 --- Cargill cannot prove its EU Article 14 claim submission [disease risk reduction claim] that there is a cause-and-effect relationship between sugar-free hard confectionery with at least 90 percent erythritol and the reduction of dental plaque, according to the European Food Safety Authority (EFSA).

Business News

Algatech eyes Brazil market following Anvisa approval for astaxanthin line

27 Jul 2017 --- Algatechnologies has received Brazilian Health Regulatory Agency (Anvisa) approval for its all-natural astaxanthin AstaPure to be used as a food ingredient. This approval makes Algatech the first astaxanthin supplier to start marketing its clean-label astaxanthin under the AstaPure brand in Brazil. 

Nutrition & Health News

Binge drinking among young US adults not in college increased

27 July 2017 --- Binge drinking rates are finally down among US college students aged 18 to 24, after years of increases, but they are up among those in the same age group who are not in college, according to a study in the July issue of the Journal of Studies on Alcohol and Drugs. The same study also found that alcohol-related hospitalizations and overdose deaths have increased generally among 18- to 24-year-olds.

Business News

Food and health startups get chance to impress in Innovation Challenge

27 Jul 2017 --- Innovative ingredient projects, carried out by startups that have brought something completely new and unexpected to the food and health markets, will be rewarded as part of the Startup Innovation Challenge during the next Fi Europe & Ni show from November 28 to 30 this year.

More Articles
URL : http://www.nutritioninsight.com:80/news/Sabinsas-DigeZyme-Shows-Benefit-For-Delayed-Onset-Muscle-Soreness.html